Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
Explore this paper's citation graph
Summary
The high incidence of symptomatic relief seen in this study, even in the absence of objective response, suggests that moderate dose chemotherapy may have a role in the palliation of NSCLC.
- Type
- article
- Published
- 1989-11-01
- Cited by
- 92
- References
- 18
- Access
- Open access
- OpenAlex
- https://openalex.org/W1986335982
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1352596
Keywords
Vinblastine, Medicine, Nausea, Chemotherapy, Cisplatin
References
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
- Benefits of polychemotherapy in advanced non‐small‐cell bronchogenic carcinoma
- Progress in chemotherapy of non-small cell lung cancer.
- Treatment of inoperable carcinoma of bronchus.
- Non-small cell lung cancer: how oncologists want to be treated.
- Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
- Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
- Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
- Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
- Reporting results of cancer treatment
- Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy.
- Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.
- Letter: Treatment of inoperable carcinoma of bronchus.
- The treatment of inoperable carcinoma.
- Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
- The role of chemotherapy in non-small cell lung cancer: the community perspective.
- Is there standard chemotherapy for non-small cell lung cancer?
- Chemotherapy in non-small cell lung cancer: results of recent trials.
Cited by
- Serum tumor markers may precede instrumental response to chemotherapy in patients with metastatic cancer.
- Treatment of patients with advanced non-small cell lung cancer
- Quality of life in patients receiving platinum based chemotherapy for advanced non-small cell lung cancer.
- Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome
- Role of chemotherapy for palliation in the lung cancer patient.
- Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
- Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
- Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.
- Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
- A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
- Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C
- Mitomycin C: a clinical update.
- Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
- Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer: A phase II trial
- Chemotherapy for advanced non-small-cell lung cancer.
- The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.
- Chemoprevention of lung cancer
- Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial.
- Chemotherapy versus best supportive care for unresectable non small cell lung cancer: is it really worthwhile?
- Non‐surgical therapy for patients with advanced non‐small cell lung cancer
Related papers
- Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.
- [Sequentially alternating chemotherapy of non-seminomatous testicular tumors with adriamycin/cisplatin and bleomycin/vinblastine. Therapeutic success and failure with respect to histology and tumor stages].
- Raynaud's phenomenon and cancer chemotherapy.
- Sustained remission of choriocarcinoma with cis-platinum, vinblastine, and bleomycin after failure of conventional combination drug therapy.
- Combination Chemotherapy to Hodgkin's Disease in a Pregnant Patient
- The treatment of combination chemotherapy‐resistant Hodgkin disease with single‐agent vinblastine
- New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers
- ADVANCED MALE NON‐SEMINOMATOUS GERM‐CELL TUMOURS